• About Us
    • Contact Us
    • Login
    • ObGFirst
  • COVID-19
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • GrandRounds
  • My Bookshelf
  • Now@ObG
  • Media
About Us Contact Us Login ObGFirst
  • COVID-19
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • GrandRounds
  • My Bookshelf
  • Now@ObG
  • Media
Grand Rounds

Foley vs Misoprotol:  What is the Most Cost-Effective Way to Induce Labor?

image_pdfFavoriteLoadingFavorite

BACKGROUND AND PURPOSE:

  • In a previous RCT (Lancet, 2016 – see ‘Related ObG Topics’ below), investigators determined that
    • Both misoprostol and Foley catheter will work when considering induction in an unfavorable cervix at term
    • 50 micrograms oral misoprosotol every 4 hours or a 30 ml transcervical Foley catheter did not show a difference in safety profile when looking at fetal asphyxia or postpartum hemorrhage
  • Eikelder et al. (BJOG, 2017) sought to assess the cost of labor induction associated with oral misoprostol vs. catheter

METHODS:

  • Economic analysis in parallel to randomized controlled trial (RCT)
  • Women with unfavorable cervix (Bishop score <6) without previous cesarean section were randomized into two in labor induction treatments:
    • Oral misoprostol (n = 924)
    • Foley catheter (n = 921)
  • Economic analysis from a hospital perspective was conducted with estimates of medical costs associated with healthcare utilization from randomization until discharge
  • The primary outcome was mean cost and differences per woman

RESULTS:

  • Mean cost per woman was similar among groups (conversion 1€=1.35$)
    • Oral misoprostol group cost €4,470 ($6,047)
    • Foley catheter group cost €4,158 ($5,625)
  • However, if Foley catheter induction was carried out in an outpatient setting and admission only at start of active labor
    • Oral misoprostol group cost €4,470 ($6,047)
    • Foley catheter group cost €3,489 ($4,720)

CONCLUSION:

  • Induction of labor using a Foley catheter or oral misoprostol are equivalent, but Foley is more cost-effective if ripening done on an outpatient basis, with the potential to save approximately €1,000 ($1,350) per woman

Learn More – Primary Sources:

Comparing induction of labor with oral misoprostol or Foley catheter at term: cost-effectiveness analysis of a randomized controlled multi-centre non-inferiority trial

image_pdfFavoriteLoadingFavorite

< Previous
All Grand Rounds Posts
Next >

Related ObG Topics:

Practical info on evidence based medicine for your women's healthcare practice
Misoprostol or Foley catheter for an unfavorable cervix at term?
Foley Bulb Catheter for Induction Following PROM in Nulliparas
Does Tension on the Foley Catheter Impact Time to Delivery?

Sections

  • COVID-19
  • Alerts
  • OB
  • GYN
    • GYN
    • Sexual Health
  • 2T US Atlas
  • The Genome
  • Primary Care
  • Your Practice
  • Grand Rounds
  • My Bookshelf
  • Now@ObG
  • Media

Are you an
ObG Insider?

Get specially curated clinical summaries delivered to your inbox every week for free

  • Site Map/
  • © ObG Project/
  • Terms and Conditions/
  • Privacy/
  • Contact Us/
© ObG Project
SSL Certificate


  • Already an ObGFirst Member?
    Welcome back

    Log In

    Want to sign up?
    Get guideline notifications
    CME Included

    Sign Up

Get Guideline Alerts Direct to Your Phone
Try ObGFirst Free!

Sign In

Lost your password?

Sign Up for ObGFirst and Stay Ahead

  • - Professional guideline notifications
  • - Daily summary of a clinically relevant
    research paper
  • - Includes 1 hour of CME every month

ObGFirst Free Trial

Already a Member of ObGFirst®?

Please log in to ObGFirst to access the 2T US Atlas

Password Trouble?

Not an ObGFirst® Member Yet?

  • - Access 2T US Atlas
  • - Guideline notifications
  • - Daily research paper summaries
  • - And lots more!
ObGFirst Free Trial

Media - Internet

Computer System Requirements

OBG Project CME requires a modern web browser (Internet Explorer 10+, Mozilla Firefox, Apple Safari, Google Chrome, Microsoft Edge). Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, or Real Networks Real One Player.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information
presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Jointly provided by

NOT ENOUGH CME HOURS

It appears you don't have enough CME Hours to take this Post-Test. Feel free to buy additional CME hours or upgrade your current CME subscription plan

Subscribe

JOIN OBGFIRST AND GET CME/CE CREDITS

One of the benefits of an ObGFirst subscription is the ability to earn CME/CE credits from the ObG entries you read. Tap the button to learn more about ObGFirst

Learn More
Leaving ObG Website

You are now leaving the ObG website and on your way to PRIORITY at UCSF, an independent website. Therefore, we are not responsible for the content or availability of this site